Exclusion Criteria:~* Significant neurological disease affecting the brain or psychiatric disease other than
AD, such as current untreated major depression, schizophrenia, epilepsy, Parkinson's disease,
Creutzfeldt-Jakob's disease, or clinical episode of stroke~* Laboratory or clinical signs of untreated,
clinically significant abnormal thyroid function, in the Investigator's opinion~* Received other
investigational drugs within 30 days or 5 half-lives prior to baseline, whichever is longer~* Taking other
medications, with the exception of estrogen, known to affect serum gonadotropin (Gn) concentrations, including
but not limited to goserelin, danazol, or leuprolide~* Other exclusion criteria exist--eligibility can be
assessed by the trial site
